96.95USD+1.65%Mkt Cap: 10.82B USDP/E: 46.61Last update: 2026-05-22
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and servi…
Industry Peers
Diagnostics & ResearchIndicators:|
Key Statistics
Company
Market Cap10.82B USD
Enterprise Value13.13B USD
Revenue (TTM)2.90B USD
Gross Profit1.56B USD
Net Income (TTM)241.20M USD
Revenue/Share25.36 USD
Last Price96.95 USD
Fiscal Year EndDec 2025
MR QuarterApr 2026
Employees11.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)46.61
P/E (Forward)16.41
PEG0.58
EV/EBITDA15.35
EV/Revenue4.52
P/S3.67
P/B1.49
EPS (TTM)2.08
EPS (Forward)5.81
52W Range
81.2242% of range118.30
52W High118.30 USD
52W Low81.22 USD
Profitability
Gross Margin54.77%
Oper. Margin12.35%
EBITDA Margin29.47%
Profit Margin8.45%
ROE3.33%
ROA1.98%
Growth
Revenue Growth7.00%
Earnings Growth3.50%
Cash Flow & Leverage
Operating CF582.93M USD
CapEx (TTM)73.52M USD
FCF Margin17.54%
FCF Yield4.71%
Net Debt2.49B USD
Net Debt/EBITDA2.91
Balance Sheet
Debt/Equity0.47
Current Ratio1.72
Quick Ratio1.25
Book Value/Sh64.20 USD
Cash/Share7.712 USD
Dividends
Fwd Div Rate0.2800 USD
Trail. Div Rate0.2800 USD
Div. Yield0.29%
5Y Avg Yield0.24%
Payout Ratio13.46%
Ex-Div DateJul 17, 2026
Pay DateAug 7, 2026
Splits
Last Split2:1
Split DateJun 4, 2001
Analyst Consensus
Rating2.2 (Buy)
Target (Mean)113.64 USD
Target Range90.00 USD – 145.00 USD
# Analysts14
Ownership
Shares Out.111.56M
Float102.14M
Insiders0.36%
Institutions105.87%
Short Interest
Short Ratio8.8d
Short % Float11.80%
Short % Out.7.87%
Shares Short8.79M
Short (prev mo.)8.24M
Technical
SMA 5090.38 (+7.3%)
SMA 20094.50 (+2.6%)
Beta1.05
S&P 52W Chg28.31%
Avg Vol (30d)1.33M
Avg Vol (10d)1.35M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—